rs137852676
| Orientation | minus |
| Stabilized | minus |
| Geno | Mag | Summary |
|---|---|---|
| (G;G) | 0 | common in clinvar |
| Make rs137852676(A;A) |
| Make rs137852676(A;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 11 |
| Position | 17395852 |
| Gene | ABCC8 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs137852676 |
| dbSNP (classic) | rs137852676 |
| ClinGen | rs137852676 |
| ebi | rs137852676 |
| HLI | rs137852676 |
| Exac | rs137852676 |
| Gnomad | rs137852676 |
| Varsome | rs137852676 |
| LitVar | rs137852676 |
| Map | rs137852676 |
| PheGenI | rs137852676 |
| Biobank | rs137852676 |
| 1000 genomes | rs137852676 |
| hgdp | rs137852676 |
| ensembl | rs137852676 |
| geneview | rs137852676 |
| scholar | rs137852676 |
| rs137852676 | |
| pharmgkb | rs137852676 |
| gwascentral | rs137852676 |
| openSNP | rs137852676 |
| 23andMe | rs137852676 |
| SNPshot | rs137852676 |
| SNPdbe | rs137852676 |
| MSV3d | rs137852676 |
| GWAS Ctlg | rs137852676 |
| Max Magnitude | 0 |
| ClinVar | |
|---|---|
| Risk | rs137852676(A;A) rs137852676(T;T) |
| Alt | rs137852676(A;A) rs137852676(T;T) |
| Reference | Rs137852676(G;G) |
| Significance | Probable-Pathogenic |
| Disease | Familial hyperinsulinism Persistent hyperinsulinemic hypoglycemia of infancy |
| Variation | info |
| Gene | ABCC8 |
| CLNDBN | Familial hyperinsulinism Persistent hyperinsulinemic hypoglycemia of infancy |
| Reversed | 1 |
| HGVS | NC_000011.9:g.17417399C>T |
| CLNSRC | Counsyl |
| CLNACC | RCV000029263.1, RCV000169150.1, |
[PMID 16357] [Pharmacokinetics of glaphenine in subjects with normal renal function and in patients with chronic renal insufficiency].
[PMID 14715863] Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation.
[PMID 17378627] Genotype-phenotype associations in patients with severe hyperinsulinism of infancy.
[PMID 17668386
] Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects.
[PMID 18025408
] Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.
[PMID 18436707
] Neonatal diabetes mellitus.
